Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Antonini

Showing results (51-60 of 495) with videos related to

Pageof 50
Sort By:
Expert Review of Neurotherapeutics|January 13, 2015
Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesiasPantelis Stathis, Spiridon Konitsiotis, Angelo Antonini
NPJ Parkinson'S Disease|July 21, 2017
Cognitive decline in Parkinson's disease: the complex pictureRoberta Biundo, Luca Weis, Angelo Antonini
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2019
Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?K Ray Chaudhuri, Peter Jenner, Angelo Antonini
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2019
Reply to: "Parkinson disease-associated dyskinesia in countries with low access to levodopa-sparing Regimens"K Ray Chaudhuri, Peter Jenner, Angelo Antonini
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 10, 2020
Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis"Andrea Lovato, Angelo Antonini, Cosimo de Filippis
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2020
Dyskinesia Matters: But Not as Much as It Used toK Ray Chaudhuri, Peter Jenner, Angelo Antonini
Journal of Neural Transmission (Vienna, Austria : 1996)|September 28, 2015
Therapy-resistant symptoms in Parkinson's diseaseRuxandra Julia Vorovenci, Roberta Biundo, Angelo Antonini
Nature Reviews. Neurology|November 4, 2024
Parkinson disease therapy: current strategies and future research prioritiesFabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
International Review of Neurobiology|October 8, 2022
Smell deficits in COVID-19 and possible links with Parkinson's diseaseAron Emmi, Michele Sandre, Andrea Porzionato, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|September 30, 2017
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?Roberta Biundo, Luca Weis, Eleonora Fiorenzato, et al.
Pageof 50

Showing results (51-60 of 495) with videos related to

Sort By:
Pageof 50
Expert Review of Neurotherapeutics|January 13, 2015
Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesiasPantelis Stathis, Spiridon Konitsiotis, Angelo Antonini
NPJ Parkinson'S Disease|July 21, 2017
Cognitive decline in Parkinson's disease: the complex pictureRoberta Biundo, Luca Weis, Angelo Antonini
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2019
Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?K Ray Chaudhuri, Peter Jenner, Angelo Antonini
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2019
Reply to: "Parkinson disease-associated dyskinesia in countries with low access to levodopa-sparing Regimens"K Ray Chaudhuri, Peter Jenner, Angelo Antonini
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 10, 2020
Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis"Andrea Lovato, Angelo Antonini, Cosimo de Filippis
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2020
Dyskinesia Matters: But Not as Much as It Used toK Ray Chaudhuri, Peter Jenner, Angelo Antonini
Journal of Neural Transmission (Vienna, Austria : 1996)|September 28, 2015
Therapy-resistant symptoms in Parkinson's diseaseRuxandra Julia Vorovenci, Roberta Biundo, Angelo Antonini
Nature Reviews. Neurology|November 4, 2024
Parkinson disease therapy: current strategies and future research prioritiesFabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
International Review of Neurobiology|October 8, 2022
Smell deficits in COVID-19 and possible links with Parkinson's diseaseAron Emmi, Michele Sandre, Andrea Porzionato, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|September 30, 2017
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?Roberta Biundo, Luca Weis, Eleonora Fiorenzato, et al.
Pageof 50